Skip to content

Clinical trials

Phase 2 Heart Failure trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2 Country / region: Sweden Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20102
20111
20122
20133
20141
20182
20212
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
AstraZeneca4
Celladon Corporation1
Karolinska Institutet1
Medtronic Cardiac Rhythm and Heart Failure1
Michael Fu1
Novartis Pharmaceuticals1
Thomas Nystrom1
Turku University Hospital1
Umeå University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure18
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
Renal Insufficiency, Chronic2
Atrial Fibrillation1
Brain Injuries1
Brain Ischemia1
Cardiomegaly1
Cardiomyopathies1
Cerebral Infarction1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.